Leuprolide Recruiting Phase 2 Trials for Alzheimer's Disease (AD) / Mild Cognitive Impairment (MCI) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03649724The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's